UG UNITED GUARDIAN INC
Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 101295 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.6%
TTM net income YoY59.6%
TTM EPS YoY—
Revenue 3-yr CAGR4.0%
Net income 3-yr CAGR7.4%
Margins
Gross margin49.7%
Operating margin25.9%
Net margin25.2%
FCF margin23.7%
EBITDA margin26.9%
Returns
ROE28.7%
ROA24.4%
ROIC (approx.)26.3%
Asset turnover0.97x
Leverage & solvency
Liabilities / assets16.8%
Debt / equity0.00x
Current ratio6.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.96x
Accruals ratio0.9%
Payout ratio80.9%
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.49M | $3.11M | $2.87M | $2.96M | $2.26M | $2.84M | $2.48M | $2.48M |
| Cost of revenue | $1.62M | $1.56M | $1.45M | $1.63M | $1.31M | $1.34M | $1.12M | $1.20M |
| Gross profit | $1.88M | $1.55M | $1.42M | $1.33M | $953,069 | $1.50M | $1.36M | $1.28M |
| R&D expense | $121,834 | $124,395 | $115,021 | $124,278 | $117,104 | $107,868 | $114,394 | $131,065 |
| Operating income | $1.11M | $754,125 | $642,449 | $721,901 | $215,072 | $695,453 | $610,922 | $556,376 |
| Pretax income | $1.17M | $917,605 | $1.03M | $817,979 | $326,475 | $790,602 | $707,959 | $640,812 |
| Income tax | $242,656 | $189,026 | $214,236 | $168,403 | $58,034 | $163,776 | $147,064 | $137,088 |
| Net income | $930,912 | $728,579 | $818,902 | $649,576 | $268,441 | $626,826 | $560,895 | $503,724 |
| EBITDA | $1.14M | $783,491 | $671,457 | $752,616 | $242,373 | $720,607 | $635,952 | $582,710 |
| EPS (basic) | 0.20 | 0.16 | 0.18 | — | 0.06 | 0.14 | 0.12 | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Dividends declared per share | 0.30 | — | 0.25 | — | 0.25 | 0.00 | 0.35 | 0.00 |
| Balance sheet | ||||||||
| Cash & equivalents | $1.41M | $2.39M | $735,854 | $1.25M | $860,836 | $1.77M | $1.27M | $1.88M |
| Short-term investments | $7.34M | $7.20M | $7.30M | $7.32M | $7.44M | $6.65M | $6.85M | $7.52M |
| Receivables | $2.39M | $1.69M | $2.01M | $1.59M | $1.16M | $1.91M | $1.55M | $1.43M |
| Inventory | $1.12M | $1.18M | $1.32M | $1.51M | $1.41M | $1.53M | $1.50M | $1.45M |
| Current assets | $12.58M | $12.71M | $11.81M | $12.20M | $11.25M | $12.47M | $11.69M | $12.67M |
| PP&E, net | $865,391 | $877,812 | $888,060 | $907,182 | $915,358 | $927,424 | $934,965 | $956,387 |
| Total assets | $13.45M | $13.59M | $12.70M | $13.11M | $12.18M | $13.39M | $12.76M | $13.80M |
| Current liabilities | $1.94M | $1.74M | $1.47M | $1.67M | $1.60M | $1.85M | $1.93M | $1.91M |
| Total liabilities | $2.26M | $1.96M | $1.80M | $1.88M | $1.60M | $1.93M | $1.93M | $1.91M |
| Shareholders' equity | $11.18M | $11.63M | $10.90M | $11.23M | $10.58M | $11.46M | $10.84M | $11.88M |
| Shares outstanding | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M |
| Cash flow statement | ||||||||
| Operating cash flow | $554,363 | $1.52M | $604,536 | $330,495 | $1.01M | $303,243 | $322,080 | $269,297 |
| Capital expenditure | $15,601 | $19,118 | $9,886 | $22,539 | $15,235 | $17,613 | $3,608 | $315,173 |
| Free cash flow | $538,762 | $1.50M | $594,650 | $307,956 | $995,766 | $285,630 | $318,472 | -$45,876 |
| Investing cash flow | -$157,377 | $134,889 | $30,113 | $59,766 | -$770,109 | $206,316 | $679,370 | -$835,558 |
| Financing cash flow | -$1.38M | $0 | -$1.15M | $0 | -$1.15M | -$10,290 | -$1.61M | $0 |
| Depreciation & amortization | $28,022 | $29,366 | $29,008 | $30,715 | $27,301 | $25,154 | $25,030 | $26,334 |
| Dividends paid | $1.38M | $0 | $1.15M | $0 | $1.15M | $10,290 | $1.61M | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.